| Literature DB >> 35922800 |
Bin Zhang1, Xiao-Yu Liu1, Bing Kang2, Chao Yuan1, Zi-Wei Li1, Zheng-Qiang Wei1, Dong Peng3.
Abstract
BACKGROUND: Whether hypokalemia can affect the short-term outcomes of CRC patients after radical surgery remains unclear. The purpose of this study was to investigate the impact of preoperative hypokalemia on the short-term outcomes for colorectal cancer (CRC) patients who underwent radical CRC surgery using propensity score matching (PSM).Entities:
Keywords: Colorectal cancer; Hypokalemia; Propensity score matching; Short-term outcomes; Surgery
Mesh:
Substances:
Year: 2022 PMID: 35922800 PMCID: PMC9347170 DOI: 10.1186/s12885-022-09950-1
Source DB: PubMed Journal: BMC Cancer ISSN: 1471-2407 Impact factor: 4.638
Fig. 1Flow chart of patient selection
Clinical characteristics of CRC patients
| Characteristics | No. 6183 |
|---|---|
| Age, year | 63.2 ± 12.3 |
| Sex | |
| Male | 3598 (58.2%) |
| Female | 2585 (41.8%) |
| BMI, kg/m2 | 22.6 ± 3.2 |
| Smoking | 2291 (37.1%) |
| Drinking | 1876 (30.3%) |
| Hypertension | 1586 (25.7%) |
| T2DM | 679 (11.0%) |
| CHD | 286 (4.6%) |
| Surgery history | 1499 (24.2%) |
| Laparoscopy | 5362 (86.7%) |
| K+ | 4.1 ± 0.4 |
| Hypokalemia | 390 (6.3%) |
| Tumor location | |
| Colon | 2982 (48.2%) |
| Rectum | 3201 (51.8%) |
| Tumor size | |
| < 5 cm | 4247 (60.2%) |
| ≥ 5 cm | 2803 (39.8%) |
| TNM stage | |
| I | 1197 (19.4%) |
| II | 2598 (42.0%) |
| III | 2388 (38.6%) |
| Blood loss, mL | 97.5 ± 144.6 |
| Operation time, min | 220.8 ± 79.4 |
| Hospital stay, day | 11.3 ± 8.1 |
| Overall complications | 1339 (21.7%) |
Note: Variables are expressed as the mean ± SD, n (%)
Abbreviations: T2DM Type 2 diabetes mellitus, BMI Body mass index, CHD Coronary heart disease
Baseline characteristics before and after PSM
| Characteristics | Before PSM | After PSM | ||||||
|---|---|---|---|---|---|---|---|---|
| Hypokalemia (390) | Normal (5793) | SMD (%) | Hypokalemia (390) | Normal (390) | SMD (%) | |||
| K+ | 3.2 ± 0.2 | 4.1 ± 0.4 | < 0.01* | — | 3.2 ± 0.2 | 4.1 ± 0.4 | < 0.01* | — |
| Age (year) | 66.9 ± 12.0 | 63.0 ± 12.2 | < 0.01* | 30.4 | 66.9 ± 12.0 | 66.7 ± 10.7 | 0.756 | 2.2 |
| Sex | < 0.01* | 32.7 | 0.217 | 8.8 | ||||
| Male | 172 (44.1%) | 3426 (59.1%) | 172 (44.1%) | 155 (39.7%) | ||||
| Female | 218 (55.9%) | 2367 (40.9%) | 218 (55.9%) | 235 (60.3%) | ||||
| BMI (kg/m2) | 22.5 ± 3.3 | 22.6 ± 3.2 | 0.538 | 3.2 | 22.5 ± 3.3 | 22.6 ± 3.3 | 0.649 | 3.3 |
| Smoking | 107 (27.4%) | 2184 (37.7%) | < 0.01* | 22.0 | 107 (27.4%) | 98 (25.1%) | 0.464 | 5.2 |
| Drinking | 79 (20.3%) | 1797 (31.0%) | < 0.01* | 24.8 | 79 (20.3%) | 74 (19.0%) | 0.652 | 3.2 |
| Hypertension | 167 (42.8%) | 1419 (24.5%) | < 0.01* | 39.5 | 167 (42.8%) | 157 (40.3%) | 0.467 | 5.2 |
| T2DM | 67 (17.2%) | 612 (10.6%) | < 0.01* | 19.2 | 67 (17.2%) | 59 (15.1%) | 0.436 | 5.6 |
| CHD | 30 (7.7%) | 256 (4.4%) | 0.003* | 13.7 | 30 (7.7%) | 25 (6.4%) | 0.484 | 5.0 |
| Surgical history | 95 (24.4%) | 1404 (24.2%) | 0.956 | 0.3 | 95 (24.4%) | 102 (26.2%) | 0.564 | 4.1 |
| Laparoscopy | 310 (79.5%) | 5052 (87.2%) | < 0.01* | 20.8 | 310 (79.5%) | 317 (81.3%) | 0.528 | 4.5 |
| Tumor size | 0.047* | 10.3 | 0.943 | 0.5 | ||||
| < 5 cm | 216 (55.4%) | 3503 (60.5%) | 216 (55.4%) | 215 (55.1%) | ||||
| ≥ 5 cm | 174 (44.6%) | 2290 (39.5%) | 174 (44.6%) | 175 (50.2%) | ||||
| Tumor location | 0.001* | 17.0 | 0.613 | 3.6 | ||||
| Colon | 219 (56.2%) | 2763 (47.7%) | 219 (56.2%) | 226 (57.9%) | ||||
| Rectum | 171 (43.8%) | 3030 (52.3%) | 171 (43.8%) | 164 (42.1%) | ||||
| Tumor stage | 0.197 | 8.3 | 0.583 | 2.2 | ||||
| I | 62 (15.9%) | 1135 (19.6%) | 62 (15.9%) | 62 (15.9%) | ||||
| II | 169 (43.3%) | 2429 (41.9%) | 169 (43.3%) | 163 (41.8%) | ||||
| III | 159 (40.8%) | 2229 (38.5%) | 159 (40.8%) | 165 (42.3%) | ||||
Note: Variables are expressed as the mean ± SD, n (%), *P-value < 0.05
Abbreviations: PSM Propensity score matching, SMD standardized mean difference, T2DM Type 2 diabetes mellitus, BMI Body mass index, CHD Coronary heart disease
Short-term outcomes before and after PSM
| Characteristics | Before PSM | After PSM | ||||
|---|---|---|---|---|---|---|
| Hypokalemia (390) | Normal (5793) | Hypokalemia (390) | Normal (390) | |||
| Operation time (min) | 217.7 ± 79.3 | 221.0 ± 79.4 | 0.432 | 217.7 ± 79.3 | 217.8 ± 87.0 | 0.985 |
| Blood loss (mL) | 111.7 ± 273.3 | 96.5 ± 131.5 | 0.044* | 111.7 ± 273.3 | 91.0 ± 96.3 | 0.158 |
| Hospital stay (day) | 12.8 ± 12.3 | 11.2 ± 7.7 | < 0.01* | 12.8 ± 12.3 | 11.2 ± 6.2 | 0.028* |
| Overall complications | 111 (28.5%) | 1228 (21.2%) | 0.001* | 111 (27.8%) | 87 (22.3%) | 0.048* |
| Anastomotic leakage | 12 (3.1%) | 144 (2.5%) | 0.471 | 111 (28.5%) | 5 (1.3%) | 0.086 |
| Incision infection | 17 (4.4%) | 198 (3.4%) | 0.326 | 12 (3.1%) | 12 (3.1%) | 0.344 |
| Pneumonia | 27 (6.9%) | 187 (3.2%) | < 0.01* | 17 (4.4%) | 11 (2.8%) | 0.008* |
| Lymph fistula | 6 (1.5%) | 37 (0.6%) | 0.051 | 27 (6.9%) | 4 (1.0%) | 0.524 |
| Ileus | 5 (1.3%) | 117 (2.0%) | 0.311 | 6 (1.5%) | 10 (2.7%) | 0.192 |
| VTE | 6 (1.5%) | 52 (0.9%) | 0.197 | 5 (1.3%) | 2 (0.5%) | 0.155 |
| Reoperation | 10 (2.3%) | 95 (1.6%) | 0.172 | 6 (1.5%) | 3 (0.8%) | 0.050 |
| Postoperative death | 7 (1.8%) | 16 (0.3%) | < 0.01* | 10 (2.3%) | 3 (0.8%) | 0.203 |
| Other complications | 45 (11.5%) | 565 (9.8%) | 0.252 | 7 (1.8%) | 46 (11.8%) | 0.911 |
Note: Variables are expressed as the mean ± SD, n (%), *P-value < 0.05
Abbreviations: PSM Propensity score matching, VTE Venous thromboembolism
Univariate and multivariate logistic regression of the overall complications of the whole cohort
| Risk factors | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|
| OR (95% CI) | OR (95% CI) | |||
| Age, year | 1.025 (1.020–1.031) | < 0.01* | 1.020 (1.014–1.026) | < 0.01* |
| Surgical methods (open/laparoscopic) | 2.275 (1.942–2.664) | < 0.01* | 1.814 (1.533–2.146) | < 0.01* |
| Sex (male/female) | 0.801 (0.708–0.908) | < 0.01* | 0.873 (0.741–1.029) | 0.105 |
| BMI, Kg/m2 | 0.980 (0.962–0.999) | 0.038* | 0.987 (0.967–1.007) | 0.189 |
| Hypertension (yes/no) | 1.320 (1.154–1.509) | < 0.01* | 1.087 (0.936–1.263) | 0.274 |
| T2DM (yes/no) | 1.473 (1.230–1.763) | < 0.01* | 1.290 (1.064–1.563) | 0.010* |
| Surgical history (yes/no) | 1.281 (1.117–1.469) | < 0.01* | 1.235 (1.071–1.425) | 0.004* |
| Tumor location (colon/ rectum) | 0.906 (0.803–1.023) | 0.111 | ||
| Tumor stage (III/II/I) | 1.013 (0.933–1.099) | 0.767 | ||
| Smoking (yes/no) | 1.257 (1.111–1.423) | < 0.01* | 1.227 (1.026–1.468) | 0.025* |
| Drinking (yes/no) | 1.141 (1.002–1.300) | 0.046* | 0.965 (0.812–1.148) | 0.690 |
| CHD (yes/no) | 1.622 (1.251–2.103) | < 0.01* | 1.283 (0.974–1.689) | 0.076 |
| Tumor size (≥ 5/ < 5), cm | 1.273 (1.126–1.439) | < 0.01* | 1.120 (0.986–1.271) | 0.081 |
| K+ (Hypokalemia/ normal), g/L | 1.479 (1.177–1.859) | 0.001* | 1.291 (1.017–1.639) | 0.036* |
| Blood loss, mL | 1.002 (1.002–1.003) | < 0.01* | 1.002 (1.001–1.002) | < 0.01* |
Abbreviations: OR Odds ratio, CI Confidence interval, BMI Body mass index, T2DM Type 2 diabetes mellitus, CHD Coronary heart disease
*P-value < 0.05